Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0128-2019

Drug recall · November 7, 2018

Catapres .2 recall

Why: Failed Dissolution Specifications: OOS resultsduring routine stability testing

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Catapres .2 (clonidine hydrochloride, USP) 0.2mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. Made in Germany. NDC 0597-0007-01

Lots / codes

Lot: 757739, EXP 9/2020

Quantity
1,380 100-count bottles
Company
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT
Distribution
Distributed nationwide in the USA and Puerto Rico
Initiated
October 22, 2018 · Voluntary: Firm initiated
Classified
November 1, 2018
Reported
November 7, 2018
Ended
April 3, 2023
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Clonidine

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.